Continued Improvement and Normalization of Myocardial T2*In Patients with beta-thalassemia Major Treated With Deferasirox (Exjade (R)) for up to 3 Years

Pennell, DudleyPorter, John B.Cappellini, Maria DomenicaChan, Lee LeeEl-Beshlawy, AmalAydinok, YesimIbrahim, HishamshahLi, Chi-KongViprakasit, VipElalfy, Mohsen SalehKattamis, AntonisSmith, GillianHabr, DanyDomokos, GaborRoubert, BernardTaher, Ali2019-10-272019-10-2720100006-4971https://hdl.handle.net/11454/4330752nd Annual Meeting of the American-Society-of-Hematology (ASH) -- DEC 04-07, 2010 -- Orlando, FLeninfo:eu-repo/semantics/closedAccessContinued Improvement and Normalization of Myocardial T2*In Patients with beta-thalassemia Major Treated With Deferasirox (Exjade (R)) for up to 3 YearsConference Object1162117351736WOS:000289662204695Q1